UMG's Board of Directors will consider distribution of dividends for the first half of 2021 on November 29
Cyprus, 15 November 2021. United Medical Group CY PLC (hereinafter referred to as "the Company", together with its subsidiaries, "the Group" or "EMC", MOEX ticker: GEMC), a leading provider of comprehensive premium medical services in Russia, operating under the brand "European Medical Center", hereby informs that a meeting of the company's Board of Directors to consider dividends distribution for the first half of 2021 will be held on November 29, 2021.
In addition to the dividends’ distribution, the agenda of the meeting include the issues on the budget for 2022, on the establishment of black-out periods on transactions with securities of the Company for insiders in accordance with the best corporate governance practices, on a long-term incentive program for the management of subsidiaries, on the opening of a credit line for a subsidiary company EMC-Holdco as well as other issues within the competence of the Board of Directors.
The full agenda of the meeting is published as a material fact on the Interfax - Corporate Information Disclosure Center page.
About the company
EMC is a leading multidisciplinary provider of premium healthcare services in Russia with the longest track record of any major private healthcare business in this market. EMC is a fully integrated healthcare services provider offering a comprehensive range of diversified medical services, and has advanced capabilities in more than 57 specialisations, differentiating it from the competition in Russia. The company utilises a patient-centric approach to its healthcare services offering, which allows it to provide patients with a full range of diagnostics and treatment services as well as offer tailor-made medical care.
EMC also is a leading Russian provider of cancer treatment with extensive expertise in a full range of modern oncology treatment methods, state-of-the-art facilities and equipment as well as renowned experts with international experience.
EMC’s network comprises seven multidisciplinary medical centres, one maternity centre and one rehabilitation centre (with a total built-up area of approximately 87 thousand square metres), as well as three geriatric centres (with a total built-up area of approximately 14 thousand square metres). As at 30 June 2021, the Group had 2,593 employees, comprising 752 physicians, 1,472 nurses and other medical staff and 369 administrative and support staff.
Company’s depository receipts have traded on Moscow Exchange since July 15, 2021, under the ticker “GEMC”.
Contacts
Investor relations
EMC
Dmitriy Ivanov
Head of Investor Relations
ir@emc-investors.com
https://emc-investor.com/
https://t.me/emcinvestor
Media relations
UMG PR
pr@emcmos.ru
EM
Dmitriy Zhadan
zhadan@em-comms.com
Ekaterina Shatalova
shatalova@em-comms.com
Important Note
NEITHER THIS ANNOUNCEMENT NOR THE INFORMATION CONTAINED HEREIN IS FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, INTO AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR TO ANY PERSON IN ANY OF THOSE JURISDICTIONS OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE LAWS OF SUCH JURISDICTION.
These materials are not intended to and do not constitute investment advice. These materials do not constitute or form any part of and should not be constructed as an offer or commitment to sell or issue, a solicitation, recommendation, commitment or invitation to subscribe for, underwrite or otherwise acquire, and should not be construed as an advertisement for, any securities of United Medical Group CY PLC or any member of its group in any jurisdiction or an inducement to enter into investment activity in any jurisdiction.
These materials have been prepared on the basis of the Group’s management accounts. These materials do not contain sufficient information to constitute a full set of financial statements. The numbers presented in this statement have not been audited.
About the company
EMC is a leading multidisciplinary provider of premium healthcare services in Russia with the longest track record of any major private healthcare business in this market.[ According to EMC’s estimates.] EMC is a fully integrated healthcare services provider offering a comprehensive range of diversified medical services, and has advanced capabilities in more than 57 specialisations, differentiating it from the competition in Russia. The company utilises a patient-centric approach to its healthcare services offering, which allows it to provide patients with a full range of diagnostics and treatment services as well as offer tailor-made medical care.
EMC also is a leading Russian provider of cancer treatment with extensive expertise in a full range of modern oncology treatment methods, state-of-the-art facilities and equipment as well as renowned experts with international experience.
EMC’s network comprises seven multidisciplinary medical centres, one maternity centre and one rehabilitation centre (with a total built-up area of approximately 87 thousand square metres), as well as three geriatric centres (with a total built-up area of approximately 14 thousand square metres).
Company’s depository receipts have traded on Moscow Exchange since July 15, 2021, under the ticker “GEMC”.
Investor relations
Dmitry Ivanov
Head of Investor Relations
Important Note
NEITHER THIS ANNOUNCEMENT NOR THE INFORMATION CONTAINED HEREIN IS FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, INTO AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR TO ANY PERSON IN ANY OF THOSE JURISDICTIONS OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE LAWS OF SUCH JURISDICTION.
These materials are not intended to and do not constitute investment advice. These materials do not constitute or form any part of and should not be constructed as an offer or commitment to sell or issue, a solicitation, recommendation, commitment or invitation to subscribe for, underwrite or otherwise acquire, and should not be construed as an advertisement for, any securities of United Medical Group CY PLC or any member of its group in any jurisdiction or an inducement to enter into investment activity in any jurisdiction.